Sequana Medical NV
XBRU:SEQUA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Henkel AG & Co KGaA
XETRA:HEN3
|
DE |
Sequana Medical NV
Other Current Liabilities
Sequana Medical NV
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sequana Medical NV
XBRU:SEQUA
|
Other Current Liabilities
€8.3m
|
CAGR 3-Years
69%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Nyxoah SA
XBRU:NYXH
|
Other Current Liabilities
€11.6m
|
CAGR 3-Years
31%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
|
Ion Beam Applications SA
XBRU:IBAB
|
Other Current Liabilities
€272.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Sequana Medical NV
Glance View
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
See Also
What is Sequana Medical NV's Other Current Liabilities?
Other Current Liabilities
8.3m
EUR
Based on the financial report for Jun 30, 2025, Sequana Medical NV's Other Current Liabilities amounts to 8.3m EUR.
What is Sequana Medical NV's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
33%
Over the last year, the Other Current Liabilities growth was 160%. The average annual Other Current Liabilities growth rates for Sequana Medical NV have been 69% over the past three years , 33% over the past five years .
